Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.66 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | CA4 | P22748 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | TNKS | O95271 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL819054 | 0.84 | CA1 (0.56) | KDM4ECA1CA2NFKB1CA4 | |
| SCHEMBL28414685 | 0.84 | CA1 (0.56) | KDM4ECA1CA2NFKB1CA4 | |
| SCHEMBL8218747 | 0.83 | KDM4E (0.66) | KDM4ECA1CA2NFKB1CA4 | |
| SCHEMBL579354 | 0.83 | KDM4E (0.54) | KDM4ECA1CA2HTTMAPT | |
| 2-Isopropyl-3-Methoxycinnamic Acid SCHEMBL2280935 | 0.80 | KDM4E (1.00) | KDM4ECA1CA2CA4MAPK1 | |
| 2-Isopropyl-3-Methoxycinnamic Acid SCHEMBL2280937 | 0.80 | KDM4E (1.00) | KDM4ECA1CA2CA4MAPK1 | |
| SCHEMBL15512 | 0.79 | KDM4E (0.47) | KDM4ECA1CA2MAPK1MAPT | |
| SCHEMBL2480692 | 0.79 | KDM4E (0.49) | KDM4ECA1CA2NFKB1CA4 | |
| SCHEMBL489850 | 0.79 | KDM4E (0.52) | KDM4ECA1CA2NFKB1CA4 | |
| SCHEMBL8575018 | 0.76 | CA1 (0.55) | KDM4ECA1CA2NFKB1CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2874507-B1 | AQUEOUS TRANSPARENT OIL-IN-WATER EMULSION COMPRISING AN EMULSIFIED CAROTENOID | BASF SE (DE) | 2020-12-30 | — | — | EP | claimed |
| EP-3307395-B1 | SOLUBILISING AGENTS FOR UV SCREENING COMPOUNDS | ISP INVESTMENTS LLC (US) | 2020-08-05 | — | — | EP | claimed |
| EP-2485807-B1 | SUN-CARE COMPOSITIONS | ISP INVESTMENTS LLC (US) | 2019-07-03 | — | — | EP | claimed |
| EP-2687103-B1 | Process for manufacturing an aqueous transparent oil-in-water emulsion comprising a carotenoid and emulsion produced | BASF SE (DE) | 2019-05-22 | — | — | EP | claimed |
| EP-1595936-B1 | COMPOSITION FOR EXTERNAL USE | VITAMIN C60 BIORES CORP (JP) | 2011-10-19 | — | — | EP | claimed |
| US-12605315-B2 | External skin preparation | KAO CORPORATION (JP) | 2026-04-21 | — | — | US | disclosed |
| US-12551424-B2 | Oil-in-water type emulsification composition containing UV wavelength conversion substance | SHISEIDO COMPANY, LTD. (JP) | 2026-02-17 | — | — | US | disclosed |
| US-12440431-B2 | Cosmetic comprising ultraviolet wavelength conversion substance | SHISEIDO COMPANY, LTD. (JP) | 2025-10-14 | — | — | US | disclosed |
| US-12419818-B2 | External preparation | KAO CORPORATION (JP) | 2025-09-23 | — | — | US | disclosed |
| US-12409118-B2 | External skin preparation | KAO CORPORATION (JP) | 2025-09-09 | — | — | US | disclosed |
| US-20250255791-A1 | POWDER COSMETIC CONTAINING ULTRAVIOLET WAVELENGTH-CONVERTING SUBSTANCE, AND METHOD FOR PRODUCING SAME | SHISEIDO COMPANY, LTD. (JP) | 2025-08-14 | — | — | US | disclosed |
| US-20250152484-A1 | OIL-IN-WATER EMULSION SKIN PREPARATION FOR EXTERNAL USE | KAO CORPORATION (JP) | 2025-05-15 | — | — | US | disclosed |
| EP-1256336-A2 | Two-phase gel composition | Penreco (US) | 2002-11-13 | — | — | EP | disclosed |
| EP-1235552-A2 | MATERIAL COMPRISING AN ORGANIC UV-A FILTER AND METHOD FOR DISPLACING THE MAXIMUM ABSORPTION WAVELENGTH | L'OREAL (FR) | 2002-09-04 | — | — | EP | disclosed |
| WO-2002055034-A2 | COSMETIC COMPOSITIONS CONTAINING A FRUCTAN, A POLYSACCHARIDE AND A BENEFICIAL AGENT, AND USES THEREOF | L'OREAL (FR) | 2002-07-18 | — | — | WO | disclosed |
| US-20020055562-A1 | Gel compositions | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2002-05-09 | — | — | US | disclosed |
| WO-2002007699-A1 | USE AND COSMETIC COMPOSITIONS OF STARCH BETAINATES | L'OREAL (FR) | 2002-01-31 | — | — | WO | disclosed |
| EP-1141111-A1 | GEL COMPOSITIONS | Penreco (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2001024768-A2 | MATERIAL COMPRISING AN ORGANIC UV-A FILTER AND METHOD FOR DISPLACING THE MAXIMUM ABSORPTION WAVELENGTH | L'OREAL (FR) | 2001-04-12 | — | — | WO | disclosed |
| WO-2000026285-A1 | GEL COMPOSITIONS | PENRECO (US) | 2000-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12605315-B2 | External skin preparation | TLR5, CUTA, TLR3 | KDM4E 1765/4885CA1 3580/4885CA2 3273/4885 |
| US-12409118-B2 | External skin preparation | CUTA, RBP4, DSG1 | KDM4E 1990/4885CA1 4804/4885CA2 4788/4885 |
| US-12551424-B2 | Oil-in-water type emulsification composition containing UV wavelength conversion substance | PCNA, CD14, TP53 | KDM4E 1150/4885CA1 4508/4885CA2 3453/4885 |
| US-20250152484-A1 | OIL-IN-WATER EMULSION SKIN PREPARATION FOR EXTERNAL USE | CUTA, NAPEPLD, LIPA | KDM4E 4099/4885CA1 4115/4885CA2 3724/4885 |
| US-12419818-B2 | External preparation | CUTA, ALOX15, HSF1 | KDM4E 3201/4885CA1 4501/4885CA2 3733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.